Skip to main content
logo
Kringle Pharma, Inc. (TYO:4884)
Japan flag Japan · Delayed Price · Currency is JPY
611.00
+47.00 (8.33%)
Oct 6, 2026, 3:30 PM JST

Kringle Pharma Ratios and Metrics

Millions JPY. Fiscal year is Oct - Sep.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Market Capitalization
5,1223,1595,7604,3182,4213,919
Market Cap Growth
66.85%-45.16%33.41%78.32%-38.21%-
Enterprise Value
4,0541,5273,3041,937-271,690
Last Close Price
611.00462.00847.00798.00450.00907.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
PS Ratio
14.9743.8772.0062.586.1913.56
PB Ratio
4.092.422.732.140.871.56
P/TBV Ratio
4.092.422.732.140.871.56
P/OCF Ratio
----161.42-

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
EV/Sales Ratio
11.8521.2141.3028.07-5.85

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Net Debt / Equity Ratio
-0.85-1.24-1.10-1.06-0.99-0.85
Asset Turnover
0.170.030.030.020.130.12
Inventory Turnover
0.33---0.270.39
Quick Ratio
9.7415.4018.5210.6117.4317.47
Current Ratio
17.1718.8521.5212.5219.8020.74
Return on Equity (ROE)
-61.23%-53.65%-36.63%-35.52%-12.50%-12.83%
Return on Assets (ROA)
-24.51%-23.50%-19.00%-19.07%-9.11%-8.98%
Return on Capital Employed (ROCE)
-42.80%-46.10%-31.10%-36.90%-14.00%-14.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Earnings Yield
-15.78%-29.00%-13.13%-19.78%-13.67%-7.68%
Buyback Yield / Dilution
-7.53%-6.92%-18.72%-11.00%-16.91%-7422.44%